WQW-47037-74056
3 vaccinations
2 coded responses
33 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 722 / AR
- Registered
- 2020-12-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-22
Registered in v-safe
-
2020-12-22
Dose 1 — Pfizer-BioNTech
-
2020-12-22
Health check-in — day 0, dose 1Feeling: Fair · Site: Redness, Itching · Headache, Muscle or body achesAdult check-in
-
2020-12-23
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2020-12-24
- 2020-12-29
- 2021-01-05
-
2021-01-12
Dose 2 — Pfizer-BioNTech
-
2021-01-12
Survey response — day 0, dose 2MedDRA: Dyspnoea, Respiratory tract congestion — Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, NauseaFree text: Congestion, slight shortness of breathMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-01-15
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-28
- 2021-02-02
- 2021-02-09
- 2021-02-16
- 2021-02-23
- 2021-04-13
- 2021-07-13
-
2021-10-29
Dose 3 — Pfizer-BioNTech
- 2021-10-29
-
2021-10-30
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-10-31
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Rash, not including the immediate area around the injection siteAdult check-in
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-05
- 2021-11-12
- 2021-11-19
- 2021-11-26
- 2021-12-03
-
2021-12-10
Survey response — day 42, dose 3MedDRA: Cough, Oropharyngeal pain, Respiratory tract congestion — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Cough, congestion, sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-01-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-22 | Pfizer-BioNTech | |
| 2 | 2021-01-12 | Pfizer-BioNTech | |
| 3 | 2021-10-29 | Pfizer-BioNTech | No |
Free text
Release 1 — day 0, dose 2
Systemic reaction (other): Congestion, slight shortness of breath
Release 10 — day 42, dose 3
Symptoms: Cough, congestion, sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release